GSK announced on Friday that the US Food and Drug Administration (FDA) has accepted its regulatory application for a ...

The new prefilled syringe has the same composition but removes the need for reconstitution, providing a more convenient option for health care providers who administer vaccines. According to the ...

British drug maker GSK plc (GSK, GSK.L) announced Friday that the US Food and Drug Administration has accepted for review the ...

London open The FTSE 100 is expected to open 14 points lower on Friday, having closed up 0.83% on Thursday at 8,319.69.

Shingrix in 2017 received US FDA approval to prevent shingles in adults aged 50 and older. Since 2021, it has been approved for use in immunocompromised patients aged 18 and up. GSK estimates around ...

Curevo’s CEO, George Simeon, will discuss updated data from Curevo’s 876-patient head-to-head trial of amezosvatein, a non-mRNA adjuvanted subunit vaccine for shingles, versus Shingrix ®.

Anthem Biosciences, an India-based CDMO, submitted a filing (PDF) at the end of 2024 to announce its plans for a 33.95 ...

GSK plc has announced that the US Food and Drug Administration (USFDA) has accepted for review the regulatory application of ...

Shares at Team Internet Group (TIG) fell nearly 12 per cent this morning after private equity firm TowerBrook Capital Partners pulled out of the bid process. TowerBrook was one of two suitors vying ...

Insider Monkey’s third quarter database indicates that 38 hedge funds were bullish on GSK plc (NYSE:GSK), compared to 36 ...